share_log

Cambridge Investment Research Advisors Inc. Boosts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cambridge Investment Research Advisors Inc. Boosts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

劍橋投資研究顧問公司增持直覺外科公司股份有限公司(納斯達克代碼:ISRG)
Defense World ·  2022/09/24 05:01

Cambridge Investment Research Advisors Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 4.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 37,663 shares of the medical equipment provider's stock after buying an additional 1,619 shares during the period. Cambridge Investment Research Advisors Inc.'s holdings in Intuitive Surgical were worth $7,559,000 as of its most recent SEC filing.

根據劍橋投資研究顧問公司提交給美國證券交易委員會(美國證券交易委員會)的最新文件,該公司在第二季度增持了直覺外科公司股份(評級代碼:ISRG-GET)4.5%。該公司持有這家醫療設備提供商37,663股股票,在此期間又購買了1,619股。截至最近提交的美國證券交易委員會申報文件,劍橋投資研究顧問公司持有的直覺外科公司股份價值7,559,000美元。

Several other institutional investors also recently added to or reduced their stakes in ISRG. Standard Family Office LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $27,000. IronBridge Private Wealth LLC increased its position in Intuitive Surgical by 200.0% during the 4th quarter. IronBridge Private Wealth LLC now owns 81 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 54 shares during the period. Comprehensive Financial Consultants Institutional Inc. purchased a new position in Intuitive Surgical during the 4th quarter valued at about $30,000. JFS Wealth Advisors LLC increased its position in Intuitive Surgical by 145.2% during the 1st quarter. JFS Wealth Advisors LLC now owns 103 shares of the medical equipment provider's stock valued at $31,000 after purchasing an additional 61 shares during the period. Finally, Vectors Research Management LLC increased its position in Intuitive Surgical by 200.0% during the 4th quarter. Vectors Research Management LLC now owns 90 shares of the medical equipment provider's stock valued at $32,000 after purchasing an additional 60 shares during the period. Hedge funds and other institutional investors own 82.44% of the company's stock.

其他幾家機構投資者最近也增持或減持了ISRG的股份。標準家族辦公室有限責任公司在第四季度購買了直覺外科公司的一個新頭寸,價值約27,000美元。鐵橋私人財富有限責任公司第四季度增持直覺外科公司股份200.0%。Ironbridge Private Wealth LLC在此期間又購買了54股,現在擁有81股這家醫療設備提供商的股票,價值2.9萬美元。綜合財務諮詢機構有限公司在第四季度購買了直覺外科公司的新頭寸,價值約30,000美元。第一季度,JFS Wealth Advisors LLC將直覺外科公司的持倉增加了145.2%。JFS Wealth Advisors LLC在此期間又購買了61股,現在擁有103股這家醫療設備提供商的股票,價值3.1萬美元。最後,Vectors Research Management LLC在第四季度將其在直覺外科公司的頭寸增加了200.0%。在此期間購買了另外60股後,向量研究管理有限責任公司現在擁有這家醫療設備提供商90股股票,價值3.2萬美元。對衝基金和其他機構投資者持有該公司82.44%的股票。

Get
到達
Intuitive Surgical
直覺外科公司
alerts:
警報:

Analyst Upgrades and Downgrades

分析師升級和下調評級

ISRG has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Intuitive Surgical from $225.00 to $205.00 in a report on Friday, July 22nd. BTIG Research lowered their target price on shares of Intuitive Surgical from $355.00 to $247.00 and set a "buy" rating for the company in a research note on Monday, July 18th. Piper Sandler lifted their target price on shares of Intuitive Surgical from $255.00 to $260.00 and gave the stock an "overweight" rating in a research note on Thursday, August 18th. The Goldman Sachs Group decreased their price objective on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating for the company in a research note on Friday, July 29th. Finally, Morgan Stanley decreased their price objective on shares of Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating for the company in a research note on Friday, July 15th. Six research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $268.00.

ISRG一直是最近一些分析師報告的主題。在7月22日星期五的一份報告中,德意志銀行將直覺外科公司股票的目標價從225.00美元下調至205.00美元。BTIG Research將直覺外科公司股票的目標價從355.00美元下調至247.00美元,並在7月18日週一的一份研究報告中為該公司設定了“買入”評級。派珀·桑德勒將直覺外科公司股票的目標價從255.00美元上調至260.00美元,並在8月18日週四的一份研究報告中給予該股“增持”評級。高盛夫婦將直覺外科公司的股票目標價從319.00美元下調至273.00美元,並在7月29日星期五的一份研究報告中為該公司設定了“買入”評級。最後,摩根士丹利將直覺外科公司股票的目標價從300.00美元下調至225.00美元,並在7月15日(星期五)的一份研究報告中為該公司設定了“同等權重”評級。6名研究分析師對該股的評級為持有,12名分析師對該公司的評級為買入。根據MarketBeat的數據,直覺外科公司目前的平均評級為“適度買入”,共識目標價為268.00美元。

Intuitive Surgical Trading Down 0.3 %

直覺外科公司股價下跌0.3%

ISRG stock opened at $190.52 on Friday. The business has a 50 day simple moving average of $218.90 and a 200-day simple moving average of $233.18. Intuitive Surgical, Inc. has a twelve month low of $186.83 and a twelve month high of $369.69. The company has a market capitalization of $68.04 billion, a P/E ratio of 48.48, a PEG ratio of 5.43 and a beta of 1.31.
ISRG股票週五開盤報190.52美元。該業務的50日簡單移動均線切入位在218.90美元,200日簡單移動均線切入位在233.18美元。直覺外科公司的股價跌至186.83美元的12個月低點和369.69美元的12個月高點。該公司市值為680.4億美元,市盈率為48.48倍,聚乙二醇率為5.43倍,貝塔係數為1.31。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last issued its quarterly earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share for the quarter, missing the consensus estimate of $1.04 by ($0.19). Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the business earned $1.42 earnings per share. Research analysts predict that Intuitive Surgical, Inc. will post 3.76 EPS for the current fiscal year.

直覺外科公司(納斯達克代碼:ISRG-GET Rating)上一次發佈季度收益報告是在7月21日星期四。這家醫療設備提供商公佈本季度每股收益為0.85美元,低於普遍預期的1.04美元(0.19美元)。直覺外科公司的股本回報率為12.04%,淨利潤率為24.05%。該公司本季度營收為15.2億美元,而分析師預期為15.6億美元。去年同期,該業務每股收益為1.42美元。研究分析師預測,直覺外科公司公司本財年每股收益將達到3.76歐元。

Insider Buying and Selling

內幕買賣

In related news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now directly owns 11,224 shares of the company's stock, valued at $2,671,760.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now directly owns 11,224 shares of the company's stock, valued at $2,671,760.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 9,000 shares of the stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the transaction, the executive vice president now owns 217 shares of the company's stock, valued at approximately $48,825. The disclosure for this sale can be found here. Insiders sold a total of 101,162 shares of company stock valued at $22,062,916 over the last three months. 0.90% of the stock is currently owned by company insiders.

在相關新聞中,董事在8月3日星期三的一次交易中出售了6,375股該公司股票。股票以238.04美元的平均價格出售,總成交金額為1,517,505.00美元。出售完成後,董事現在直接擁有11,224股該公司股票,價值2,671,760.96美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站。在相關新聞中,董事在8月3日星期三的一次交易中出售了6,375股該公司股票。股票以238.04美元的平均價格出售,總成交金額為1,517,505.00美元。出售完成後,董事現在直接擁有11,224股該公司股票,價值2,671,760.96美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站。此外,執行副總裁米里亞姆·庫雷特在7月27日星期三的一次交易中出售了9000股該股。這隻股票的平均售價為225.00美元,總價值為2,025,000.00美元。交易完成後,執行副總裁總裁現在持有該公司217股股票,價值約48,825美元。關於這次銷售的披露可以找到這裏。過去三個月,內部人士總共出售了101,162股公司股票,價值22,062,916美元。公司內部人士目前持有該公司0.90%的股份。

About Intuitive Surgical

關於直覺外科公司

(Get Rating)

(獲取評級)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

直覺外科公司公司開發、製造和營銷產品,使醫生和醫療保健提供者能夠在美國和國際上提高微創護理的質量和獲得微創護理的機會。該公司提供達芬奇外科系統,以實現使用微創方法進行復雜手術;以及離子腔內系統,將其商業產品從外科擴展到能夠進行微創肺活組織檢查的診斷程序。

Recommended Stories

推薦故事

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • 2 Semiconductor Stocks To Watch For Reversals
  • 免費獲取斯托克新聞網關於直覺外科公司的研究報告
  • MarketBeat:回顧一週9/19-9/23
  • 為什麼特斯拉的股票保持彈性?
  • 好市多盈利後價格疲軟是買入的好時機嗎?
  • 小盤股的裁員是樓市的晴雨表嗎?
  • 需要關注的2只半導體類股走勢逆轉

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直覺外科公司日報》的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊接收對直覺外科公司及相關公司的最新新聞和分析師評級的每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論